Home
About
Overview
Sharing Data
ORCID
Help
History (7)
Immunotherapy: a new standard of care in thoracic malignancies? A summary of the European Respiratory Society research seminar of the Thoracic Oncology Assembly.
LKB1 Deficiency Renders NSCLC Cells Sensitive to ERK Inhibitors.
Nickson, Pamela
Hostile attributional bias, negative emotional responding, and aggression in adults: moderating effects of gender and impulsivity.
Early-Stage Lung Cancer: Using Circulating Tumor DNA to Get Personal.
See All 7 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Early-Stage Lung Cancer: Using Circulating Tumor DNA to Get Personal.
Early-Stage Lung Cancer: Using Circulating Tumor DNA to Get Personal. J Clin Oncol. 2023 09 01; 41(25):4093-4096.
View in:
PubMed
subject areas
Biomarkers, Tumor
Carcinoma, Non-Small-Cell Lung
Circulating Tumor DNA
Humans
Lung Neoplasms
authors with profiles
Marina Chiara Garassino
Everett Vokes
Christine Bestvina